Universal-Beteiligungs- und Servicegesellschaft’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Sell
97,047
-7,651
-7% -$117K ﹤0.01% 1298
2026
Q1
$1.45M Buy
104,698
+30,172
+40% +$481K ﹤0.01% 1372
2025
Q4
$1.21M Buy
74,526
+42,109
+130% +$687K ﹤0.01% 1430
2025
Q3
$485K Buy
32,417
+20,911
+182% +$255K ﹤0.01% 1757
2025
Q2
$134K Buy
+11,506
New +$105K ﹤0.01% 1973

Other funds holding ADPT

Universal-Beteiligungs- und Servicegesellschaft's ADPT Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Adaptive Biotechnologies (ADPT) stake by 7.3% in Q2 2026, selling an estimated $117K and leaving 97,047 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ADPT in Q2 2025 and has held it in 5 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 97,047 shares of Adaptive Biotechnologies worth $2.08M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 7,651 Adaptive Biotechnologies shares in Q2 2026, an estimated $117K.
  • Adaptive Biotechnologies made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1298 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Adaptive Biotechnologies in Q2 2025 and has held it in 5 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.